LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 63 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $218,435 | -59.0% | 148,595 | -11.3% | 0.00% | -100.0% |
| Q2 2023 | $532,675 | +250.9% | 167,508 | +160.4% | 0.00% | – |
| Q1 2023 | $151,819 | -37.0% | 64,330 | -7.3% | 0.00% | – |
| Q4 2022 | $240,891 | -51.9% | 69,421 | +1.6% | 0.00% | -100.0% |
| Q3 2022 | $501,000 | +3.9% | 68,336 | -7.6% | 0.00% | 0.0% |
| Q2 2022 | $482,000 | +50.2% | 73,990 | +16.3% | 0.00% | – |
| Q1 2022 | $321,000 | +224.2% | 63,593 | +398.0% | 0.00% | – |
| Q4 2021 | $99,000 | -47.6% | 12,769 | 0.0% | 0.00% | – |
| Q3 2021 | $189,000 | – | 12,769 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $156,056,000 | 45.49% |
| Foresite Capital Management IV, LLC | 13,282,181 | $102,804,000 | 21.15% |
| Apoletto Ltd | 15,093,969 | $116,827,000 | 14.55% |
| SB Management Ltd | 3,500,000 | $27,090,000 | 2.68% |
| HSG Holding Ltd | 3,045,997 | $23,576,000 | 2.11% |
| MIC Capital Management UK LLP | 1,320,000 | $10,217,000 | 1.95% |
| Alphabet Inc. | 5,865,125 | $45,396,000 | 1.10% |
| Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $12,754,000 | 0.80% |
| Adero Partners, LLC | 491,372 | $3,803,000 | 0.62% |
| Ergoteles LLC | 1,008,428 | $7,805,000 | 0.30% |